352 related articles for article (PubMed ID: 19950292)
1. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-induced accelerated cryoprecipitation in hepatitis C virus-associated mixed cryoglobulinemia has parallels with intravenous immunoglobulin-induced immune complex deposition in mixed cryoglobulinemia: comment on the article by Sène et al.
Misbah SA
Arthritis Rheum; 2010 Oct; 62(10):3122; author reply 3122-3. PubMed ID: 20662059
[No Abstract] [Full Text] [Related]
3. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
5. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
6. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
Cacoub P; Hausfater P; Musset L; Piette JC
Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
[TBL] [Abstract][Full Text] [Related]
7. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
8. Observations on cryoglobulin testing: I. The association of cryoglobulins containing rheumatoid factors with manifestation of cryoglobulinemic vasculitis.
De Rosa FG; Agnello V
J Rheumatol; 2009 Sep; 36(9):1953-5. PubMed ID: 19531750
[TBL] [Abstract][Full Text] [Related]
9. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
10. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
[TBL] [Abstract][Full Text] [Related]
11. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
12. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
13. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
[TBL] [Abstract][Full Text] [Related]
16. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
18. Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia.
Terrier B; Sène D; Dechartres A; Saadoun D; Ortonne N; Rouvier P; Musset L; Rigon MR; Maisonobe T; Cacoub P
J Rheumatol; 2011 Jan; 38(1):104-10. PubMed ID: 20952479
[TBL] [Abstract][Full Text] [Related]
19. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Visentini M; Granata M; Veneziano ML; Borghese F; Carlesimo M; Pimpinelli F; Fiorilli M; Casato M
Clin Immunol; 2007 Oct; 125(1):30-3. PubMed ID: 17692572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
